Hamps Bio Ltd.

HAMPS

₹44.62

4.99% (2.12)

Market Cap

₹19 Cr.

P/E

36.97

About

Hamps Bio is a company involved in the ethical marketing and distribution of pharmaceutical formulation products like tablets, syrups, capsules, injectables, and more. They also manufacture freeze-dri… Read more

Hamps Bio is a company involved in the ethical marketing and distribution of pharmaceutical fo… Read more

Low

52W Range

High

107

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

6 Yes

Positive for this company

1 Neutral

Neutral for this company

3 No

Negative for this company

7 No Data

Insufficient data to analyse

Accounting & Shareholding

Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Promoter Holding

Promoter has not sold any shares in the last 90 days
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales
Contingent Liabilities

Unable to calculate due to limited data
Retail Holding

Unable to calculate due to limited data
Pledge

Unable to calculate due to limited data

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Share price

Share price has decreased over last 10 years more due to earnings
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Unable to calculate due to limited data
Sales Growth

Unable to calculate due to limited data
Margin Stability

Unable to calculate due to limited data
ROCE Strength

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up - Pharmaceuticals

Product Wise Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Peer Comparison

FAQs on Hamps Bio Ltd. Business

What does Hamps Bio do?

Hamps Bio is engaged in the ethical marketing and distribution of pharmaceutical formulation products (Pharma) across wide range of dosage including tablets, syrups, capsules, injectables, oil, gel and powder used as medicine and nutrition supplements as well as the manufacturing of freeze dried and frozen products (FDFP or FMCG Division) such as fruits, vegetables, herbs and flowers.

Who are the competitors of Hamps Bio?

Hamps Bio major competitors are Mono Pharmacare, Chandra Bhagat Pharm, Sotac Pharmaceutical, Phaarmasia.
Market Cap of Hamps Bio is ₹19 Crs.
While the median market cap of its peers are ₹44 Crs.

Is Hamps Bio financially stable compared to its competitors?

Hamps Bio seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

[]

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Hamps Bio Ltd.